Added to YB: 2026-08-06
Pitch date: 2026-08-04
SN.L [neutral]
Smith & Nephew plc
-2.03%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
Market Cap
GBP 12.7B
Pitch Price
GBP 11.31
Price Target
N/A
Dividend
2.59%
EV/EBITDA
10.14
P/E
20.51
EV/Sales
2.50
Sector
Health Care Equipment and Supplies
Category
N/A
Smith & Nephew (SN/ UK): Not good enough
SN.L (earnings): Q2 miss; underlying rev growth slowed to 1.6%, FY organic guide cut from ~6% to ~4%. Ortho (Knees pre-Landmark launch) & Advanced Wound (US skin substitute reimbursement) weak; Sports Med/ENT strong. H1 trading profit +8%, FY ~8% guide held. Slower rev caps re-rating.
Read full article (2 min)